Oversold Stocks to watch

 Money.Maker
 
  Money.Maker
 
Follow  Message
 
 
 
Investment analyst known for his analytical prowess and ability to uncover hidden investment opportunities. With a background in economics and a passion for data-driven decision-making, Kevin has earned a reputation for delivering results.
 

•  30 Jan 2026
 

•   ABT  
   
  +3.03%
•   CRDF  
   
  +8.02%
•   DCBO  
   
  +0.15%
•   ELME  
   
  +0.92%
•   EMBC  
   
  +3.01%

$ABT Abbott Laboratories has found itself on Jim Cramer’s radar lately, but the technicals tell a story of a stock that has been hit hard, currently sitting in a downtrend. We’re seeing a slight tick up in the RSI from 19.83 to 19.98, which is just enough to suggest the selling pressure might finally be exhausted near these 52-week lows of $105.27. If the broader market stabilizes, this high-quality name could be looking at a technical snapback toward its 20-day moving average.

$LOGI Logitech is showing a classic scenario where shares fell despite a strong Q3 earnings beat and rising revenues. The RSI has made a significant leap from a deeply oversold 3.65 to 29.45, indicating that the initial panic selling is being absorbed by buyers. With gaming and video collaboration still showing fundamental strength, keep an eye on this one for a potential oversold bounce as it attempts to reclaim the $90 level.

$SONY Sony Group has been languishing in a downtrend, but the recent launch of its LinkBuds Clip suggests the product engine is still humming. Technically, the stock is trading just above its 52-week low of $20.42 with an RSI that’s starting to point its head up from 17.42 to 17.66. It’s a slow turn, but in this tape, any sign of life in a name like Sony is worth watching for a mean-reversion trade.

$NUKK Nukkleus Inc. is showing a massive divergence in its momentum indicators following the acquisition of Israeli drone firm Nimbus. The RSI has surged from 7.89 to 28.62, even as the price remains pinned near the lows. This kind of explosive RSI move often precedes a price pop, as the market begins to price in the expansion into the unmanned aerial systems sector.

$DCBO Docebo Inc. remains a favorite for growth-oriented analysts at Needham, and the chart is starting to reflect that "buy the dip" sentiment. We’ve seen a sharp RSI reversal from 25.22 to 40.87, which is a significant momentum shift. As a high-growth education tech player, this bounce off the $18 range could have some legs if it can clear initial resistance.

$HPQ HP Inc. is struggling with secular headwinds and a lack of catalysts, recently hitting a 52-week low of $19.27. However, the RSI has turned up from 22.55 to 28.52, suggesting a short-term bottom may be in place. With a high dividend yield now at 6.2%, value seekers might be stepping in here to provide a floor for an intraday reversal.

$MMYT MakeMyTrip Limited is seeing a technical signal that’s hard to ignore as the MACD has crossed above its signal line. The RSI is following suit, rising from 21.39 to 27.01. This suggests the travel giant is seeing a rotation of interest back into the name after a brutal sell-off from its 52-week highs.

$EMBC Embecta Corp. is quietly showing signs of a recovery after presenting at the J.P. Morgan Healthcare Conference. The RSI has staged a notable recovery from 4.19 to 26.46. While it’s still in a downtrend, the volume is starting to support this base-building process near the $10 mark.

$ROPR Roper Technologies is entering a critical window as investors digest its latest earnings expectations. The RSI has nudged up from 13.26 to 18.05. It’s still very deep in oversold territory, but the uptick suggests that the pre-earnings jitters might be providing a setup for a relief rally if the numbers are less bad than feared.

$ELME Elme Communities has seen its RSI stay relatively flat at 17.07, but the stock is hugging its 52-week low of $2.16 with high relative volume. For a stock that was recently added to the S&P SmallCap 600, this extreme oversold condition is becoming a coiled spring that could snap back on any positive sector news.

$CRDF Cardiff Oncology is attempting to stabilize after a 32% plunge triggered by a leadership change. The RSI is stuck at 25.36, but the price action has turned sideways, which is often the first step in a bottoming process. Traders should look for a break back above $2.00 to confirm that the worst of the liquidation is over.

View All Headlines